On January 6, 2021, Newlink Technology Inc. ("Newlink"; Stock Code: 09600.HK) completed its IPO and listing on the Main Board of the Hong Kong Stock Exchange (HKEX).

Newlink is an IT solutions provider focusing on traditional, software-driven solutions for financial institutions. The company is also committed to providing innovative, software-driven solutions, including data classification and image and text recognition technologies for both financial institutions and medical institutions. The company also provides healthcare IT solutions in China, including its flagship medical quality control and safety warning system, which enables hospital supervisors and department directors to monitor the behavior of healthcare professionals on a real-time basis. The company's solutions enable financial institutions, healthcare institutions and other enterprises to achieve intelligent business processing and data visualization, improve operational efficiency and optimize service quality. According to a China Insights Consultancy report, the company is among the top 100 of over 2,500 providers of IT solutions for financial institutions in China in terms of revenues in 2019.

As the Chinese legal adviser to the sponsor, Jingtian & Gongcheng's legal team provided one-stop, end-to-end legal services for Newlink’s IPO and listing, including its red-chip restructuring within a two-month timeframe, conducting Chinese legal due diligence, assisting in third-party due diligence, and assisting in answering inquiries from the regulator.